C-C. Lin
- Hepatology top 5%
- Biotechnology top 10%
-
- Liver Disease Diagnosis and Treatment 4
-
- Cancer Immunotherapy and Biomarkers 5
- Colorectal Cancer Treatments and Studies 4
- HER2/EGFR in Cancer Research 3
-
- Lung Cancer Treatments and Mutations 10
- Prostate Cancer Treatment and Research 4
-
- Radiopharmaceutical Chemistry and Applications 3
- Monoclonal and Polyclonal Antibodies Research 3
- Journals
- Annals of Oncology (23 papers)British Journal of Cancer (3 papers)Cell Death Discovery (1 paper)
- Partner nations
- TaiwanUnited StatesSouth Korea
In The Last Decade
C-C. Lin
41 papers receiving 552 citations
Peers
Comparison fields: 5 of 68
- Hepatology 166
- Biotechnology 93
- Cancer Research 101
- Epidemiology 207
- Oncology 107
Countries citing papers authored by C-C. Lin
This map shows the geographic impact of C-C. Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C-C. Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C-C. Lin more than expected).
Fields of papers citing papers by C-C. Lin
This network shows the impact of papers produced by C-C. Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C-C. Lin. The network helps show where C-C. Lin may publish in the future.
Co-authorship network
The 25 scholars most cited alongside C-C. Lin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 6 | |
| 3 | 2024 | 1 | |
| 4 | 2024 | 1 | |
| 5 | 2023 | 1 | |
| 6 | 2023 | 6 | |
| 7 | 2023 | 3 | |
| 8 | 2023 | 3 | |
| 9 | 2020 | 2 | |
| 10 | 2020 | 3 | |
| 11 | 2020 | 1 | |
| 12 | 2020 | 5 | |
| 13 | 2020 | 5 | |
| 14 | 2020 | 1 | |
| 15 | 2017 | 3 | |
| 16 | 2017 | 4 | |
| 17 | 2014 | 29 | |
| 18 | 2012 | 9 | |
| 19 | 2010 | 131 | |
| 20 | The relationship of pain, uncertainty, and hope in Taiwanese lung cancer patients | 2003 | 1 |
About C-C. Lin
C-C. Lin is a scholar working on Oncology, Hepatology, Pulmonary and Respiratory Medicine, Immunology and Transplantation, having authored 43 papers that have together received 559 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (10 papers), Cancer Immunotherapy and Biomarkers (5 papers), Liver Disease Diagnosis and Treatment (4 papers), Colorectal Cancer Treatments and Studies (4 papers), Prostate Cancer Treatment and Research (4 papers), Radiopharmaceutical Chemistry and Applications (3 papers), HER2/EGFR in Cancer Research (3 papers) and Monoclonal and Polyclonal Antibodies Research (3 papers). The work is most often cited by research in Hepatology (166 citations), Biotechnology (93 citations), Cancer Research (101 citations), Epidemiology (207 citations) and Oncology (107 citations). C-C. Lin has collaborated with scholars based in Taiwan, United States and South Korea. Frequent co-authors include Chen Cj, Chul‐Su Yang, Jin‐Shing Chen, Lin Tm, L-T. Chen, J. A. Thomson, Pei‐Jer Chen, Shuo Chen, Yee Chao and TS Yang. Their work appears in journals such as Annals of Oncology, British Journal of Cancer, Cell Death Discovery, Cell Death and Disease and British Journal of Radiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.